Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Health & Fitness
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/a0/78/ec/a078ec14-8913-c9d0-cee6-88a216d3a307/mza_15918992936147292073.jpg/600x600bb.jpg
S&P Pharma Dose
S&P Global Ratings
35 episodes
4 days ago
Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.
Show more...
Business
News,
Business News
RSS
All content for S&P Pharma Dose is the property of S&P Global Ratings and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.
Show more...
Business
News,
Business News
Episodes (20/35)
S&P Pharma Dose
What Bausch RemainCo's Credit Quality Post-Spinoff Could Look Like
5 years ago
7 minutes 6 seconds

S&P Pharma Dose
Regeneron Pharmaceuticals: Steady Growth vs. Heavy Product Concentration
5 years ago
8 minutes 2 seconds

S&P Pharma Dose
Episode 34: More Color on PPD's Rating After IPO
5 years ago
6 minutes 48 seconds

S&P Pharma Dose
Episode 33: Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations
5 years ago
10 minutes 25 seconds

S&P Pharma Dose
Episode 32: Pfizer Finds Home For Upjohn, Though Lessened Diversity Results In Lower Rating
6 years ago
8 minutes 45 seconds

S&P Pharma Dose
Episode 31: Thoughts On Pharma's Washington Grilling
6 years ago
12 minutes 8 seconds

S&P Pharma Dose
Episode 30: Rebates And Pharma Supply Chain
7 years ago
10 minutes 6 seconds

S&P Pharma Dose
Episode 29: Just When You Thought It Was Safe to Go Back In the Water - Amazon Buys PillPack
7 years ago
17 minutes 26 seconds

S&P Pharma Dose
Episode 28: President Trump's American Patient First Speech - Placebo?
7 years ago
10 minutes 38 seconds

S&P Pharma Dose
Episode 27: Bezos, Buffett, and Dimon - Welcome to the Healthcare Party
7 years ago
13 minutes 56 seconds

S&P Pharma Dose
Episode 26: Generic Drug Pricing - When Does the Pain Stop?
7 years ago
17 minutes 38 seconds

S&P Pharma Dose
Episode 25: Four Things We Are Watching For On Teva
7 years ago
18 minutes 3 seconds

S&P Pharma Dose
Episode 24: Et Tu Amazon? Amazon and Impact on Pharma Pricing
7 years ago
9 minutes 16 seconds

S&P Pharma Dose
Episode 23: CVS Health Possibly Seeks to Buy Aetna - Surprised? You Shouldn't Be
8 years ago
7 minutes 56 seconds

S&P Pharma Dose
Episode 22: Reflections - Mylan NV Earnings 2Q17
8 years ago
11 minutes 27 seconds

S&P Pharma Dose
Episode 21: Endo Intl Downgrade to 'B' - Litigation, Generics, and Opioids
8 years ago
13 minutes 48 seconds

S&P Pharma Dose
Episode 20: Rite Aid Corp. - What's Next For the Company?
8 years ago
8 minutes 31 seconds

S&P Pharma Dose
Episode 19: Reflections - Eli Lilly Earnings 2Q17
8 years ago
10 minutes 32 seconds

S&P Pharma Dose
Episode 17: Pharma Outlook in 7 Minutes
8 years ago
9 minutes 8 seconds

S&P Pharma Dose
Episode 16: Four Takeaways - Amgen Inc.
8 years ago
12 minutes 20 seconds

S&P Pharma Dose
Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.